Oncology Views & Analysis

Views & Analysis

Oncology

Are radiopharmaceuticals the next breakthrough in oncology?

Ben Hargreaves examines what advantages radiopharmaceuticals offer in the treatment of cancer and why there has been interest from big pharma in developing these types of therapies.

Oncology

AI-derived cancer vaccines: the pharmaphorum podcast

Today on the pharmaphorum podcast, Editor in Chief Jonah Comstock welcomes Hedi Ben Brahim and Eric Quéméneur, CEO and chief science off

Oncology

Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ...

Researchers also dove into socio-economic disparities in cancer care.

Oncology

New horizons in breast cancer care

Interview with Markus Kosch, Daiichi Sankyo head of Oncology Business Division in Europe.

Oncology

Cancer Research UK teams up with Sosei Heptares

Anatomy of a partnership: Cancer Research UK teams up with S...

Cancer Research UK is working with global biopharma Sosei Heptares on a treatment they hope will bring immunotherapy benefits to new cancer types.

Digital

AI tissue analysis enables rapid discovery of drug candidate...

AI could address the most significant issue in drug discovery, finds Ben Hargreaves, and also offers the potential to use tissue samples to create precision medicine for specific patient gr

Are radiopharmaceuticals the next breakthrough in oncology?

AI-derived cancer vaccines: the pharmaphorum podcast

Checkpoint inhibitors, Enhertu in spotlight as ASCO resumes ...

New horizons in breast cancer care

Anatomy of a partnership: Cancer Research UK teams up with S...

AI tissue analysis enables rapid discovery of drug candidate...

Biogen, Ionis trumpet Alzheimer's data, but shares dip

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks